Implanet S.A. (EPA:ALIMP)
0.1766
+0.0046 (2.67%)
Jul 13, 2026, 1:59 PM CET
Implanet Market Cap
Implanet has a market cap or net worth of €25.4 million as of July 13, 2026. Its market cap has increased by 89.94% in one year.
Market Cap
25.40M
Enterprise Value
28.31M
Revenue
12.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.18
Market Cap Chart
Since November 25, 2013, Implanet's market cap has decreased from 107.08M to 25.40M, a decrease of -76.28%. That is a compound annual growth rate of -10.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 25.40M | 1.87% |
| Dec 31, 2025 | 24.93M | 75.00% |
| Dec 31, 2024 | 14.25M | 442.72% |
| Dec 29, 2023 | 2.62M | -47.64% |
| Dec 30, 2022 | 5.01M | 23.77% |
| Dec 31, 2021 | 4.05M | -24.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 213.45M |
| Median Technologies | 176.51M |
| Guerbet | 114.80M |
| Theraclion | 49.86M |
| Mauna Kea Technologies | 32.01M |
| Diagnostic Medical Systems | 30.97M |
| Novacyt | 29.67M |
| Ikonisys | 23.76M |